Asia Pacific Respiratory Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Asia Pacific Respiratory Therapeutic Devices Market is segmented by Type (Diagnostic and Monitoring Devices and Therapeutic Devices), Disposables (Masks, Breathing Circuits, Other Disposables), and Geography (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific). The report offers value in USD million for the above segments.

Asia Pacific Respiratory Devices Market Size

Single User License
Team License
Corporate License
Book before:
View Global Report
Asia Pacific Respiratory Devices Market Summary
share button
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 5.10 %

Major Players

Asia Pacific Respiratory Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

OFF

Team License

OFF

Corporate License

OFF
Book before:

Asia Pacific Respiratory Devices Market Analysis

The Asia-Pacific respiratory devices market is expected to register a CAGR of 5.1% during the forecast period.

COVID-19 has impacted the growth of the respiratory devices market in Asia-Pacific. For instance, according to a paper published in the British Journal of Surgery, an estimated 585,000 elective procedures were postponed in India alone during the 12-week shutdown, and 28.4 million elective procedures were canceled or postponed globally by May 2020. Moreover, major respiratory devices, such as ventilators, nebulizers, CPAP, BiPAP, and oxygen concentrators, witnessed high demand initially, as they are widely being used for COVID-19 patients. Thus, with the increased severity of COVID-19 in the region, several companies have increased their ventilator production to combat the pandemic. For instance, in April 2020, MEKICS Co. Ltd, a South Korean company, partnered with BIOLASE Inc. to supply ICU-grade portable ventilators through BIOLASE's FDA-registered manufacturing facility in California. Such partnerships have increased the production of portable ventilators in the country, hence impacting the market growth. Hence, the COVID-19 pandemic had a favorable impact on the market initially; currently, as the pandemic has subsided, the market has lost some traction and is expected to have stable growth during the forecast period of the study.

Factors such as the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary diseases, TB, asthma, and sleep apnea, and technological advancements, as well as increasing applications in healthcare settings, are boosting market growth.

The prevalence and incidence of respiratory diseases such as asthma, chronic obstructive pulmonary diseases, and others among the population are increasing rapidly, which is anticipated to increase the demand for respiratory devices, hence propelling market growth. For instance, according to an article published in the WHO in March 2022, it has been observed that the prevalence of COPD was highest in North India and Bangladesh. In addition, as per the same source, the prevalence of chronic bronchitis ranged between 3% to 5%. Thus, the prevalence of COPD, a serious public health issue, is expected to rise, especially in emerging countries which is anticipated to increase the demand for different respiratory devices such as inhalers, nebulizers, ventilators, and others. This, in turn, is anticipated to fuel the market growth over the forecast period.

Additionally, the rising government activities and initiatives to donate respiratory devices to other countries to combat the coronavirus pandemic have also increased the production of respiratory devices in the region. This is also contributing to the market growth. For instance, in March 2022, the Ministry of Health and Family Welfare, as part of the National Health Mission's Reproductive, Maternal, Newborn, Child, Adolescent, and Adolescent Health and Nutrition (RMNCHA+N) program, developed the SAANS (Social Awareness and Actions to Neutralize Pneumonia Successfully) Initiative to reduce deaths from Childhood Pneumonia in both rural and urban areas which are expected to show significant growth over the forecast period. Also, in June 2021, the South Korean government donated 350 oxygen concentrators and 35 ventilators to help Indonesia cope with an exponential spike in COVID-19 cases. South Korea disbursed USD 4 million in funds to help Indonesia as a manifestation of cooperation to increase its capacity to handle the COVID-19 pandemic.

Furthermore, the rising company activities are also contributing to market growth. For instance, in November 2021, HoneyNaps, a South Korea-based healthcare startup, launched its medical software that uses artificial intelligence to diagnose sleep disorders. The device is called SOMNUM, the deep learning-based analysis program that enables real-time, multi-channel, large-capacity signal analysis. It automatically provides polysomnography readings that are said to be more accurate than conventional autoscoring.

Moreover, the increasing product launches in the region are expected to boost market growth. For instance, in March 2021, Vyaire Medical launched the AioCare (HealthUp SA, Poland) mobile spirometry system in more than 15 countries, including Australia and other countries. This new technology allows physicians to promptly diagnose pulmonary diseases, including asthma and COPD, as accurately as hospital-grade spirometers and performs high-quality patient monitoring via advanced digital connectivity at home.

Therefore, owing to the aforementioned factors, such as the high burden of respiratory diseases, government initiatives, and rising company activities, the studied market is anticipated to grow over the forecast period. However, the high cost of devices is likely to hinder the growth of the respiratory devices market in the Asia-Pacific region over the forecast period.

Asia Pacific Respiratory Devices Market Trends

This section covers the major market trends shaping the APAC Respiratory Devices Market according to our research experts:

Ventilator Segment is Expected to Hold Significant Market Share Over the Forecast Period

The ventilator segment is expected to witness significant growth in the respiratory devices market over the forecast period owing to the factors such as the rising prevalence of asthma, COPD, allergic rhinitis, brain injuries, cardiac arrest, and strokes among the population.

A ventilator is an equipment that delivers mechanical ventilation by moving breathable air into and out of the lungs to deliver breaths to a patient who is unable or insufficiently breathing. Modern ventilators are microprocessor-controlled computers; however, patients can also be ventilated using a simple, hand-operated bag valve mask. Ventilators are most employed in intensive care, home care, emergency medicine, and anesthesiology. In addition, ventilators are used in the treatment of various respiratory diseases, and the growing prevalence of these diseases is expected to boost the segment's growth.

The rising burden of COPD, coupled with the growing geriatric population who are more prone to develop chronic obstructive pulmonary disease due to the age-associated changes in the structure and function of the lung, is also expected to increase the demand for different respiratory devices, thereby bolstering the segment growth. For instance, according to an article published in the Journal of Thoracic Disease in June 2021, it has been observed that the prevalence rate of COPD was higher among people aged 40 years or over. Also, as per the data published by Statistics Korea, in September 2022, the population aged 65 years or over is expected to reach 17.5% of the total population in 2022, and South Korea is predicted to become one of the most aged societies by 2025 when the elderly population will reach 20.6% of the total population. Thus, the expected increase in the aging population is anticipated to augment the market growth.

Furthermore, the rising product launches increase the availability of innovative respiratory devices, which is also expected to fuel the segment's growth. For instance, in May 2022, Max ventilator launched multifunctional noninvasive ventilators which come with inbuild oxygen therapy and humidifier in India. Also, in June 2021, ISRO launched a portable critical care ventilator, Prana (Programmable Respiratory Assistance for the Needy Aid), and is based on the automated compression of an Ambu (Artificial Manual Breathing Unit) bag.

Therefore, owing to the factors such as the high burden of COPD, and the growing aging population in the region, the studied segment is expected to grow over the forecast period.

Asia Pacific Respiratory Devices Market - Number of Ventilators, by State, India, As of April 2021

India is Estimated to Have Significant Share in the Asia-Pacific Respiratory Devices Market Over the Forecast Period

India is expected to witness significant growth in the respiratory devices market in the Asia-Pacific region over the forecast period owing to the factors such as the growing incidence of respiratory disorders, increasing government initiatives, and the presence of market players in the country.

The rising burden of respiratory diseases such as asthma and COPD is the key factor driving the market growth in the country. For instance, according to an article published in Lung India in August 2022, it has been observed that the prevalence of asthma ranged from 2% in Karnataka to 18.2% in Rajasthan. In addition, as per the same source, the prevalence of asthma among children was 7.9%. Also, as per an article published in Bulletin WHO in December 2021, it has been observed that the prevalence of COPD in India was highest in South India, followed by Northern India. Thus, the high burden of respiratory diseases raises the demand for inhalers and other respiratory devices, thereby propelling the market growth in the country.

Furthermore, the rising company activities in developing technologically advanced respiratory devices and increasing product launches are also expected to fuel the market growth in the country. For instance, in November 2021, Cipla Limited launched Spirofy, India's first pneumotach-based portable, wireless Spirometer, on World COPD Day. Also, in June 2021, DetelPro launched DetelPro Oxy10, a pulse oximeter having an LED display that helps users easily check the results. In addition, the auto-shut-off feature of the DetelPro pulse oximeter kicks in after 8 seconds of inactivity.

Therefore, owing to the aforementioned factors, such as the high burden of asthma and COPD and increasing product launches, the studied market is expected to grow over the forecast period.

Asia Pacific Respiratory Devices Market - Estimated Number of Cumulative Coronavirus Cases and Deaths, India, as of February 2023

Asia Pacific Respiratory Devices Industry Overview

The Asia-Pacific respiratory devices market is consolidated with many players in the market. The companies are implementing certain strategic initiatives, such as a merger, new product launches, acquisitions, and partnerships that help them in strengthening their market position. Some of the companies which are currently dominating the market are GE Healthcare, Fisher & Paykel Healthcare Ltd, Koninklijke Philips NV, Smiths Medical, Dragerwerk AG, Teleflex Incorporated, 3M Company, and DeVilbiss Healthcare LLC (Drive DeVilbiss Healthcare) among others.

Asia Pacific Respiratory Devices Market Leaders

  1. GE Healthcare (GE Company)

  2. Fisher & Paykel Healthcare Ltd

  3. Dragerwerk AG

  4. Koninklijke Philips

  5. Hamilton Medical

*Disclaimer: Major Players sorted in no particular order

Asia- Pacific Respiratory Devices Market Concentration
bookmark Need More Details on Market Players and Competitors?
Download PDF

Asia Pacific Respiratory Devices Market News

  • July 2022: Vivos Therapeutics received multiple Class I clearances by the Therapeutic Goods Administration for multiple indications to include the treatment of snoring and obstructive sleep apnoea (mild, moderate, and severe) for both adults and children for its series of oral appliances.
  • July 2022: OMRON Healthcare, Japan-based company, launched a portable oxygen concentrator that is designed to aid the home care providers who are managing the therapy and lifestyle needs of patients with COPD and respiratory problems.

Asia Pacific Respiratory Devices Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Respiratory Disorders, such as Chronic Obstructive Pulmonary Disease Patients (COPD), TB, Asthma, and Sleep Apnea

      2. 4.2.2 Technological Advancements and Increasing Applications in Homecare Setting

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Devices

    4. 4.4 Porter Five Forces

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 5.1 By Type

      1. 5.1.1 Diagnostic and Monitoring Devices

        1. 5.1.1.1 Spirometers

        2. 5.1.1.2 Sleep Test Devices

        3. 5.1.1.3 Peak Flow Meters

        4. 5.1.1.4 Pulse Oximeters

        5. 5.1.1.5 Capnographs

        6. 5.1.1.6 Other Diagnostic and Monitoring Devices

      2. 5.1.2 Therapeutic Devices

        1. 5.1.2.1 CPAP Devices

        2. 5.1.2.2 BiPAP Devices

        3. 5.1.2.3 Humidifiers

        4. 5.1.2.4 Nebulizers

        5. 5.1.2.5 Oxygen Concentrators

        6. 5.1.2.6 Ventilators

        7. 5.1.2.7 Inhalers

        8. 5.1.2.8 Other Therapeutic Devices

      3. 5.1.3 By Disposables

        1. 5.1.3.1 Masks

        2. 5.1.3.2 Breathing Circuits

        3. 5.1.3.3 Other Disposables

    2. 5.2 Geography

      1. 5.2.1 China

      2. 5.2.2 Japan

      3. 5.2.3 India

      4. 5.2.4 Australia

      5. 5.2.5 South Korea

      6. 5.2.6 Rest of Asia-Pacific

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 GE Healthcare

      2. 6.1.2 Fisher & Paykel Healthcare Ltd

      3. 6.1.3 Koninklijke Philips NV

      4. 6.1.4 Medtronic Plc

      5. 6.1.5 Dragerwerk AG

      6. 6.1.6 Teleflex Incorporated

      7. 6.1.7 3M Company

      8. 6.1.8 DeVilbiss Healthcare LLC (Drive DeVilbiss Healthcare)

      9. 6.1.9 Hamilton Medical

      10. 6.1.10 ResMed

      11. 6.1.11 Masimo Inc.

      12. 6.1.12 VYAIRE

      13. 6.1.13 Getinge AB

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
bookmark You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Asia Pacific Respiratory Devices Industry Segmentation

As per the scope of the report, respiratory devices include respiratory diagnostic devices, therapeutic devices, and breathing devices for administering long-term artificial respiration. It may also include a breathing apparatus used for resuscitation by forcing oxygen into the lungs of a person who has undergone asphyxia. The Asia-Pacific Respiratory Devices Market is Segmented by type (diagnostic and monitoring devices (spirometers, sleep test devices, peak flow meters, pulse oximeters, capnographs, other diagnostic and monitoring devices), therapeutic devices (CPAP devices, BiPAP devices, humidifiers, nebulizers, oxygen concentrators, ventilators, inhalers, other therapeutic devices), disposables (masks, breathing circuits, other disposables)), and geography (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific). The report offers value in USD million for the above segments.

By Type
Diagnostic and Monitoring Devices
Spirometers
Sleep Test Devices
Peak Flow Meters
Pulse Oximeters
Capnographs
Other Diagnostic and Monitoring Devices
Therapeutic Devices
CPAP Devices
BiPAP Devices
Humidifiers
Nebulizers
Oxygen Concentrators
Ventilators
Inhalers
Other Therapeutic Devices
By Disposables
Masks
Breathing Circuits
Other Disposables
Geography
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
customize-icon Need A Different Region Or Segment?
Customize Now

Asia Pacific Respiratory Devices Market Research FAQs

The Asia-Pacific Respiratory Devices Market is projected to register a CAGR of 5.10% during the forecast period (2024-2029)

GE Healthcare (GE Company), Fisher & Paykel Healthcare Ltd, Dragerwerk AG, Koninklijke Philips and Hamilton Medical are the major companies operating in the Asia-Pacific Respiratory Devices Market.

The report covers the Asia-Pacific Respiratory Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia-Pacific Respiratory Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Asia Pacific Respiratory Devices Industry Report

Statistics for the 2024 Asia Pacific Respiratory Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia Pacific Respiratory Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Asia Pacific Respiratory Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)